Cargando…
Federally Qualified Health Centers Can Expand Rural Access to Buprenorphine for Opioid Use Disorder in Arizona
Medication for Opioid Use Disorder (MOUD) is recommended, but not always accessible to those who desire treatment. This study assessed the impact of expanding access to buprenorphine through federally qualified health centers (FQHCs) in Arizona. We calculated mean drive-times to Arizona opioid treat...
Autores principales: | Brady, Benjamin R, Gildersleeve, Rachel, Koch, Bryna D, Campos-Outcalt, Doug E, Derksen, Daniel J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365010/ https://www.ncbi.nlm.nih.gov/pubmed/34408434 http://dx.doi.org/10.1177/11786329211037502 |
Ejemplares similares
-
Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID
por: Meyerson, Beth E., et al.
Publicado: (2022) -
Colorectal Cancer Burden and Access to Federally Qualified Health Centers in California
por: Darsie, Brendan, et al.
Publicado: (2015) -
Opportunities and Challenges: Hepatitis C Testing and Treatment Access Experiences Among People in Methadone and Buprenorphine Treatment During COVID-19, Arizona, 2021
por: Meyerson, Beth E., et al.
Publicado: (2022) -
Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021) -
Experiences at a Federally Qualified Health Center Support Expanded
Conception of the Gifts of Precision Medicine
por: Neuhaus, Carolyn P., et al.
Publicado: (2021)